1519 results about "Erythritol" patented technology

Providing a D-psicose-containing sweetener with the modification of the taste of D-psicose, comprising D-psicose, a sugar alcohol and / or a high intensity sweetener, preferably containing D-psicose as the main component, particularly a low-calorie sweetener and / or a sweetener giving refreshing feel in the oral cavity, as well as foods and drinks obtained by using the D-psicose-containing sweetener with the modification of the taste of D-psicose, and other products given with sweetness. The sugar alcohol is one or more sugar alcohols selected from the group consisting of sorbitol, mannitol, lactitol, maltitol, xylitol and erythritol, while the high intensity sweetener is one or more high intensity sweeteners as selected from aspartame, acesulfame K, sodium cyclamate, sodium saccharin, Sucralose (under trade name), stevia sweetener, dulcin, taumatin, neotame and monellin.

A combination of one or more non-nutritive sweeteners, a sugar alcohol and D-tagatose are included in a reduced-calorie beverage or food product to achieve a taste substantially similar to that of a full-calorie beverage or food product. The combination is suitable for use in reduced-calorie frozen carbonated beverages. Preferably, the one or more non-nutritive sweeteners include one or more steviosides, a Stevia glycoside, a derivative of a Stevia glycoside, a glycoside of steviol, or a Lo Han Guo extract.

The invention provides an orally disintegrating tablet containing (a) one or more saccharides or sugar alcohols selected from the group consisting of mannitol, lactose, xylitol, sucrose, erythritol and glucose and (b) low substituted hydroxypropylcellulose and substantially free of a starch disintegrant, which tablet is produced by steps of granulating a composition containing the above-mentioned components (a) and (b) by an agitation granulation method, and compression-molding the obtained granulation product. The invention also provides a method of producing an orally disintegrating tablet substantially free of a starch disintegrant, including steps of granulating a composition containing the above-mentioned components by an agitation granulation method, and compression-molding the obtained granulation product.

A solid preparation which comprises (i) a pharmaceutically active ingredient, (ii) one or more water-soluble sugar alcohols selected from the group consisting of sorbitol, maltitol, reduced starch saccharide, xylitol, reduced palatinose and erythritol, and (iii) low-substituted hydroxypropylcellulose having hydroxypropoxyl group contents of 7.0 to 9.9 percent by weight; which exhibits excellent buccal disintegration and dissolution and also appropriate strength.

A solid preparation which comprises (i) a pharmaceutically active ingredient, (ii) one or more water-soluble sugar alcohol selected from the group consisting of sorbitol, maltitol, reduced starch saccharide, xylitol, reduced palatinose and erythritol, and (iii) low-substituted hydroxypropylcellulose having hydroxypropoxyl group contents of 7.0 to 9.9 percent by weight; which exhibits excellent buccal disintegration and dissolution and also appropriate strength.

The invention discloses a yarrowia lipolytica strain and a method thereof for synthesizing erythritol. The yarrowia lipolytica strain is yarrowia lipolytica BLC13 CGMCC NO. 7326. The method for synthesizing the erythritol by the yarrowia lipolytica strain comprises the following steps of: taking a carbon source with an initial fermentation concentration of 100-400g / L, a nitrogen source with an initial fermentation concentration of 2-35g / L and inorganic salt as raw materials, treating for 30 minutes at 80-90 DEG C, cooling down and subsequently inoculating the yarrowia lipolytica strain, carrying out continuous fermentation or in-batch fed-batch fermentation under an aerobic condition, and after the fermentation is accomplished, purifying the erythritol from a fermentation liquid. The yarrowia lipolytica strain disclosed by the invention is used for synthesizing the erythritol from glucose, the conversion rate is high, and the Chinese erythritol standard is met.

The present invention is aimed at providing a dry powder inhalation with minimal adhesive-agglomerative property during storage and with a good inhalation behavior for a pharmaceutically active ingredient, and is a dry powder inhalation wherein at least an active ingredient is adhered to the surface of a carrier particle comprised of erythritol and / or trehalose. It is also a dry powder inhalation wherein at least S-36496 and / or Pralmorelin dihydrochloride is adhered to the surface of the carrier particle. It is further a dry powder inhalation wherein at least an active ingredient and a surface modifier are adhered to the surface of the carrier particle. It is also a preparation method of these. Said dry powder inhalation may be applied to the capsules for use in an inhaler device. In addition to the achievement of above objectives, the present invention provides a dry powder inhalation with improved taste in inhalation or with reduced discomfort in the oral cavity and the throat, and a preparation method for enabling an easy preparation thereof without complicated processes.

A biodegradable injection mouldable polymer composition including on a dry weight basis from 45-85% w / w by weight of a starch and / or a modified high amylose starch, from 2-15% w / w by weight of a water soluble polymer preferably selected from polyvinyl alcohol, polyvinyl acetate and copolymers of ethylene and vinyl alcohol which have a melting point compatible with the molten state of the starch components, and from 5-45% w / w by weight of one or more polyol plasticizers having a molecular weight in the range of 50-6000, more preferably 50-2500, and still more preferably 100-400 and preferably selected from the group consisting of sorbitol, glycerol, maltitol, xylitol, mannitol, erythritol, polyglycerol, glycerol trioleate, tributyl citrate, acetyl tri-ethyl citrate, glyceryl triacetate, 2,2,4-trimethyl-1,3-pentanediol diisobutyrate, polyethylene oxide, ethylene glycol, diethylene glycol or polyethylene glycol; more preferably glycerol, maltitol, sorbitol, erythritol and xylitol. The composition is preferably substantially soluble in water.

The invention relates to the technical field of compound sugar, in particular to an erythritol crystal, which comprises erythritol and sweet agents accounting for 1 to 2.5 percent of the weight of the erythritol. A preparation method of the erythritol crystal comprises the following steps that the erythritol and the sweet agents are mixed and dissolved to obtain liquid solution, the solution is simultaneously evaporated and crystallized, and the erythritol crystals are obtained; the erythritol and the sweet agents are mixed and are dissolved to obtain liquid solution, the liquid solution is subjected to non-evaporation crystallization, the filtering is carried out after the crystallization completion, and the erythritol crystals are obtained; the erythritol and the sweet agents are mixed in a solid from; and the mixed solids are subjected to melting, crystallization, crushing and drying to obtain the erythritol crystals. The sweetness of the erythritol is improved and reaches more than 80 percent of the sweetness of the cane sugar, the consistency of ingredients of compound products of the erythritol and the sweet agents is realized, the problem of cocrystallization of the erythritol and the sweet agents easily carbonized at high temperature is solved, the crystallization rate is improved to the maximum degree, the crystallization efficiency is 5 to 20 percent higher than that of the traditional crystallization technology, and the application field of the product is enlarged.

The invention provides a protein in a form that is functional for the enzymatic conversion of 2C-methyl-D-erythritol 2,4-cyclodiphosphate to 1-hydroxy-2-methyl-2-butenyl 4-diphosphate notably in its (E)-form of the non-mevalonate biosynthetic pathway to isoprenoids. The invention also provides a protein in a form that is functional for the enzymatic conversion of 1-hydroxy-2-methyl-2-butenyl 4-diphosphate, notably in its (E)-form, to isopentenyl diphosphate and / or dimethylallyl diphosphate. Further, screening methods for inhibitors of these proteins are provided. Further, 1-hydroxy-2-methyl-2-butenyl 4-diphosphate is provided and chemical and enzymatic methods of its preparation.

A novel dough-like mixture made using cellulose and hydrocolloid gums that can be used as a basis for forming a variety of low-calorie foods is disclosed. Methods for producing low-calorie and reduced-starch donuts, fillings, cookies, breads, and many other food products using this dough are also described. Erythritol-based reduced-sugar confectionery items and methods for their production and application, including use in reduced-calorie sweet-tasting bakery goods, are also disclosed. Many of the disclosed foods are low enough in caloric value to be termed “recreational solid foods,” with experiments showing that even ad libitum eating of them results in weight loss.